Related Experiment Video

Updated: Aug 7, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

[Perspectives on postgenome medicine: Gene therapy for lung cancer]

K Hagiwara1, Y Saijo

  • 1Respiratory Medicine and Translational Research Clinic, Tohoku University Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 24, 2001
PubMed

Insights

Japan is advancing gene and immunotherapy for lung cancer. Research explores novel viral vectors and gene functions for next-generation cancer treatments.

Area of Science:

  • Oncology
  • Gene Therapy
  • Immunotherapy

Context:

  • Gene and immunotherapies targeting specific molecules are emerging in Japan.
  • The first human lung cancer gene therapy involves intratumoral injection of an adenoviral vector with wild-type p53 gene.
  • A Phase I clinical trial is evaluating a cancer immunotherapy based on Cyclophilin B-derived peptide.

Purpose:

  • To review current and planned next-generation cancer therapies in Japan.
  • To discuss ideal combinations of future cancer remedies based on laboratory-level investigations.
  • To highlight advancements in viral vector technology and gene introduction strategies.

Summary:

  • Clinical trials in Japan are initiating gene therapy for lung cancer using adenoviral vectors and immunotherapy with Cyclophilin B peptides.
  • Next-generation cancer therapies are being developed, including novel viral vectors and targeted gene functions.
  • The article reviews potential approaches and discusses optimal combinations for future cancer treatments.

Impact:

  • Provides an overview of cutting-edge cancer treatment strategies in Japan.
  • Highlights the potential of gene and immunotherapy for lung cancer.
  • Informs future research directions for developing combination cancer therapies.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...